Preoperative glycated hemoglobin and coronary surgery: need for different cut-offs for a continuous variable
The prevalence of diabetes mellitus is increasing. Consequently, there is an increased need for diagnostic, prognostic and therapeutic investigation (1). For years, glycated hemoglobin (HbA1c) is an important preoperative marker in diabetics. It aims now to a predictive role.